Ledger.Open graph →
SEC Form D · filed September 8, 2014

Avalanche Biotechnologies, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MENLO PARK, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Steven D. Schwartz · Menlo Park, CADirectorJohn D. Mclaughlin · Menlo Park, CADirectorPaul D. Wachter · Menlo Park, CADirectorThomas W. Chalberg · Menlo Park, CAExec · DirectorMark S. Blumenkranz · Menlo Park, CADirectorDan Novaes · Chicago, ILExec · DirectorNick Mcevily · Chicago, ILDirectorWilliam Engles · Boca Raton, FLDirectorScott Barry · NEW YORK, NYDirectorPetri Vainio, M.D., Ph.D · NEW YORK, NYDirectorLinda Bain · Menlo Park, CAExecMehdi Gasmi · Menlo Park, CAExecHans Hull · Menlo Park, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗